HRSA Clarifies Use of 340B Drugs in New Hospital Clinics, Ends COVID “Waiver”
On October 26, the Health Resources and Services Administration (HRSA) issued a notice clarifying the registration requirements for offsite hospital outpatient facilities under the 340B drug pricing program.
HRSA Clarifies Use of 340B Drugs in New Hospital Clinics, Ends COVID “Waiver”
On October 26, the Health Resources and Services Administration (HRSA) issued a notice clarifying the registration requirements for offsite hospital outpatient facilities under the 340B drug pricing program.
